BERKELEY, Calif., Nov. 1, 2010 (GLOBE NEWSWIRE) -- XOMA Ltd. (Nasdaq:XOMA), a leader in the discovery and development of antibody therapeutics, announced that it has been awarded grants totaling $977,917 under the Patient Protection and Affordable Care Act of 2010. The grants are intended to advance four of XOMA's ongoing therapeutic antibody development projects:
